ADMA Biologics, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated June 21, 2022, details the results of ADMA Biologics, Inc.'s 2022 Annual Meeting of Stockholders. The filing reports on corporate governance matters, including director elections, equity plan approvals, and executive compensation votes.
Key Financial Metrics
This filing is a corporate governance report and does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. No financial statements or metrics are included in this document.
Material Changes
The filing reports the following material corporate actions approved by stockholders:
- Director Elections: Two Class III directors, Jerrold B. Grossman and Lawrence P. Guiheen, were elected to serve until the 2025 Annual Meeting.
- Equity Plan Approval: Stockholders approved the ADMA Biologics, Inc. 2022 Equity Compensation Plan.
- Executive Compensation: The "Say-on-Pay" proposal regarding named executive officer compensation was approved on an advisory basis.
- Auditor Ratification: The appointment of CohnReznick LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2022, was ratified.
Guidance, Outlook, and Risks
The filing contains no management guidance, financial outlook, risk factors, or discussion of contingencies. It strictly reports the voting outcomes of the Annual Meeting.
Key Facts for Investor Verification
- Voting Participation: Of 196,091,777 shares outstanding, 140,309,294 shares were represented at the meeting, constituting a quorum.
- Director Support: Jerrold B. Grossman received 97,657,992 "For" votes; Lawrence P. Guiheen received 96,486,906 "For" votes.
- Equity Plan Support: The 2022 Equity Plan received 94,008,724 "For" votes against 6,146,254 "Against" votes.
- Say-on-Pay Support: Executive compensation approval received 94,938,796 "For" votes against 5,332,324 "Against" votes.
- Auditor Support: The ratification of CohnReznick LLP received 138,610,710 "For" votes against 1,517,616 "Against" votes.